array:24 [
  "pii" => "S217420491500032X"
  "issn" => "21742049"
  "doi" => "10.1016/j.repce.2014.08.020"
  "estado" => "S300"
  "fechaPublicacion" => "2015-02-01"
  "aid" => "586"
  "copyright" => "Sociedade Portuguesa de Cardiologia"
  "copyrightAnyo" => "2014"
  "documento" => "article"
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Rev Port Cardiol. 2015;34:111-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3694
    "formatos" => array:3 [
      "EPUB" => 184
      "HTML" => 2869
      "PDF" => 641
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0870255115000062"
      "issn" => "08702551"
      "doi" => "10.1016/j.repc.2014.08.021"
      "estado" => "S300"
      "fechaPublicacion" => "2015-02-01"
      "aid" => "586"
      "copyright" => "Sociedade Portuguesa de Cardiologia"
      "documento" => "article"
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "Rev Port Cardiol. 2015;34:111-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 3365
        "formatos" => array:3 [
          "EPUB" => 207
          "HTML" => 2395
          "PDF" => 763
        ]
      ]
      "en" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
        "titulo" => "Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "pt"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "111"
            "paginaFinal" => "116"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "pt" => array:1 [
            "titulo" => "An&#225;lise da terap&#234;utica de redu&#231;&#227;o lip&#237;dica e dos fatores que afetam a regularidade da toma de estatinas em doentes com doen&#231;as cardiovasculares inseridos no Registo Profile"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "pt" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Figure 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 1601
                "Ancho" => 1587
                "Tamanyo" => 104430
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Differences between groups by LDL level&#46; 1&#58; taking statins regularly&#59; 2 not taking statins&#59; 3&#58; taking statins irregularly&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Oleg Gaisenok, Sergey Martsevich, Svetlana Tripkosh, Yulia Lukina"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Oleg"
                "apellidos" => "Gaisenok"
              ]
              1 => array:2 [
                "nombre" => "Sergey"
                "apellidos" => "Martsevich"
              ]
              2 => array:2 [
                "nombre" => "Svetlana"
                "apellidos" => "Tripkosh"
              ]
              3 => array:2 [
                "nombre" => "Yulia"
                "apellidos" => "Lukina"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S217420491500032X"
          "doi" => "10.1016/j.repce.2014.08.020"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217420491500032X?idApp=UINPBA00004E"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255115000062?idApp=UINPBA00004E"
      "url" => "/08702551/0000003400000002/v3_201706020139/S0870255115000062/v3_201706020139/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2174204915000331"
    "issn" => "21742049"
    "doi" => "10.1016/j.repce.2014.08.021"
    "estado" => "S300"
    "fechaPublicacion" => "2015-02-01"
    "aid" => "587"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "article"
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Cardiol. 2015;34:117-23"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2979
      "formatos" => array:3 [
        "EPUB" => 181
        "HTML" => 2272
        "PDF" => 526
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Musculoskeletal complaints in cardiac rehabilitation&#58; Prevalence and impact on cardiovascular risk factor profile and functional and psychosocial status"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "117"
          "paginaFinal" => "123"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Dor m&#250;sculo-esquel&#233;tica em reabilita&#231;&#227;o card&#237;aca&#58; preval&#234;ncia e impacto no perfil de risco cardiovascular e estado funcional e psicossocial"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jos&#233; Afonso Rocha, Thomas G&#46; Allison, Jos&#233; Miguel Santoalha, V&#237;tor Ara&#250;jo, Fernando Parada Pereira, Maria J&#250;lia Maciel"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Jos&#233; Afonso"
              "apellidos" => "Rocha"
            ]
            1 => array:2 [
              "nombre" => "Thomas G&#46;"
              "apellidos" => "Allison"
            ]
            2 => array:2 [
              "nombre" => "Jos&#233; Miguel"
              "apellidos" => "Santoalha"
            ]
            3 => array:2 [
              "nombre" => "V&#237;tor"
              "apellidos" => "Ara&#250;jo"
            ]
            4 => array:2 [
              "nombre" => "Fernando"
              "apellidos" => "Parada Pereira"
            ]
            5 => array:2 [
              "nombre" => "Maria J&#250;lia"
              "apellidos" => "Maciel"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0870255115000074"
        "doi" => "10.1016/j.repc.2014.08.022"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255115000074?idApp=UINPBA00004E"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204915000331?idApp=UINPBA00004E"
    "url" => "/21742049/0000003400000002/v2_201502270337/S2174204915000331/v2_201502270337/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2174204915000318"
    "issn" => "21742049"
    "doi" => "10.1016/j.repce.2014.08.019"
    "estado" => "S300"
    "fechaPublicacion" => "2015-02-01"
    "aid" => "585"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "article"
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Cardiol. 2015;34:103-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4306
      "formatos" => array:3 [
        "EPUB" => 214
        "HTML" => 3350
        "PDF" => 742
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Prevalence of dyslipidemia in adolescents&#58; Comparison between definitions"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "103"
          "paginaFinal" => "109"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Preval&#234;ncia de dislipidemias em adolescentes&#58; compara&#231;&#227;o entre diferentes crit&#233;rios"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 2024
              "Ancho" => 1638
              "Tamanyo" => 136954
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Prevalence of dyslipidemia subclassifications in male &#40;A&#41; &#40;n&#61;423&#41; and female &#40;B&#41; &#40;n&#61;577&#41; adolescents&#44; according to the three diagnostic definitions&#46; HDL-C&#58; high-density lipoprotein cholesterol&#59; LDL-C&#58; low-density lipoprotein cholesterol&#59; TC&#58; total cholesterol&#59; TG&#58; triglycerides&#46; &#42; p&#60;0&#46;05 &#40;BSC&#8800;NCEP&#8800;NHANES&#41;&#59; &#8224; p&#60;0&#46;05 &#40;BSC&#61;NCEP&#62;NHANES&#41;&#59; &#8225; p&#60;0&#46;05 &#40;BSC&#62;NCEP&#61;NHANES&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Crisieli M&#46; Tomeleri, Enio R&#46;V&#46; Ronque, Danilo R&#46;P&#46; Silva, Crivaldo G&#46; Cardoso J&#250;nior, R&#244;mulo A&#46; Fernandes, Denilson C&#46; Teixeira, D&#233;cio S&#46; Barbosa, Danielle Venturini, Alessandra M&#46; Okino, Jair A&#46; Oliveira, Edilson S&#46; Cyrino"
          "autores" => array:11 [
            0 => array:2 [
              "nombre" => "Crisieli M&#46;"
              "apellidos" => "Tomeleri"
            ]
            1 => array:2 [
              "nombre" => "Enio R&#46;V&#46;"
              "apellidos" => "Ronque"
            ]
            2 => array:2 [
              "nombre" => "Danilo R&#46;P&#46;"
              "apellidos" => "Silva"
            ]
            3 => array:2 [
              "nombre" => "Crivaldo G&#46;"
              "apellidos" => "Cardoso J&#250;nior"
            ]
            4 => array:2 [
              "nombre" => "R&#244;mulo A&#46;"
              "apellidos" => "Fernandes"
            ]
            5 => array:2 [
              "nombre" => "Denilson C&#46;"
              "apellidos" => "Teixeira"
            ]
            6 => array:2 [
              "nombre" => "D&#233;cio S&#46;"
              "apellidos" => "Barbosa"
            ]
            7 => array:2 [
              "nombre" => "Danielle"
              "apellidos" => "Venturini"
            ]
            8 => array:2 [
              "nombre" => "Alessandra M&#46;"
              "apellidos" => "Okino"
            ]
            9 => array:2 [
              "nombre" => "Jair A&#46;"
              "apellidos" => "Oliveira"
            ]
            10 => array:2 [
              "nombre" => "Edilson S&#46;"
              "apellidos" => "Cyrino"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0870255115000050"
        "doi" => "10.1016/j.repc.2014.08.020"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255115000050?idApp=UINPBA00004E"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204915000318?idApp=UINPBA00004E"
    "url" => "/21742049/0000003400000002/v2_201502270337/S2174204915000318/v2_201502270337/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
    "titulo" => "Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "111"
        "paginaFinal" => "116"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Oleg Gaisenok, Sergey Martsevich, Svetlana Tripkosh, Yulia Lukina"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Oleg"
            "apellidos" => "Gaisenok"
            "email" => array:1 [
              0 => "ogaisenok&#64;gnicpm&#46;ru"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Sergey"
            "apellidos" => "Martsevich"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Svetlana"
            "apellidos" => "Tripkosh"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Yulia"
            "apellidos" => "Lukina"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "FGBI &#8220;National Research Centre of Preventive Medicine&#8221; of the Ministry of Healthcare of the Russian Federation&#44; Moscow&#44; Russia"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "FGBI &#8220;Joint Hospital and Polyclinic&#8221; Department of Presidential Affairs of the Russian Federation&#44; Moscow&#44; Russia"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "IM&#46; Sechenov First Moscow State Medical University&#44; Moscow&#44; Russia"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "An&#225;lise da terap&#234;utica de redu&#231;&#227;o lip&#237;dica e dos fatores que afetam a regularidade da toma de estatinas em doentes com doen&#231;as cardiovasculares inseridos no Registo Profile"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1593
            "Ancho" => 1578
            "Tamanyo" => 149939
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Differences between groups by LDL level&#46; 1&#58; taking statins regularly&#59; 2 not taking statins&#59; 3&#58; taking statins irregularly&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The value of statins to achieve target levels of total cholesterol&#44; low-density lipoprotein &#40;LDL&#41; cholesterol&#44; high-density lipoprotein &#40;HDL&#41; cholesterol&#44; and triglycerides is emphasized in current international guidelines&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">1</span></a> The relationship between LDL level and frequency of cardiovascular events has been confirmed in large studies&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">2&#8211;7</span></a> However&#44; clinicians do not always follow the recommendations&#46;<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">8</span></a> The situation with regard to the use of lipid-lowering drugs in Russia is particularly difficult&#46; A study of statin use in Moscow obtained the following results&#58; only 30&#37; of patients with coronary heart disease &#40;CHD&#41; took statins&#59; 80&#37; of prescriptions were for simvastatin or lovastatin at initial doses&#59; and mean duration of treatment was five months&#46;<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">9</span></a> However&#44; this study investigated selective samples of patients&#46; Data that are more relevant to clinical practice are obtained from studies conducted using the principles of consistent inclusion of patients&#44; i&#46;e&#46; under registry rules&#46;<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">10</span></a> Analysis of the drugs taken as outpatients by high-risk patients before a reference myocardial infarction in the LIS study enrolled in the hospital&#39;s registry showed that the frequency of statin use was only 2&#37;&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">11</span></a> With modern cardiovascular disease registries it is possible not only to determine the frequency of drug prescriptions but also to assess the factors that influence compliance with medication&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Objective</span><p id="par0010" class="elsevierStylePara elsevierViewall">The aim of this study was to analyze the quality of lipid-lowering therapy in a cohort of patients with cardiovascular disease enrolled in a Moscow-based registry&#44; and to analyze the factors affecting the regularity of statin administration in this patient category&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Methods</span><p id="par0015" class="elsevierStylePara elsevierViewall">The PROFILE registry is a outpatient registry compiled by the Preventive Pharmacotherapy Department of the National Research Center for Preventive Medicine &#40;NRCPM&#41; of the Ministry of Healthcare of the Russian Federation&#46; NRCPM is a federal medical center to which patients from other medical institutions &#40;including municipal&#41; are referred to seek medical advice&#46; The PROFILE registry includes all patients presenting to the department for consultations on cardiovascular disease&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">This study included all patients who sought medical advice in the Preventive Pharmacotherapy Department between May 1 and December 31&#44; 2011&#46; Each patient was given a specially designed questionnaire in order to assess compliance with the prescribed treatment&#46; Patients were required to answer the following questions&#58; &#40;1&#41; if they knew&#44; according to the results of previous exams&#44; that they had elevated cholesterol levels &#40;yes&#44; no&#44; don&#8217;t know&#41;&#59; &#40;2&#41; what method of hypercholesterolemia correction they used &#40;diet&#44; medication&#44; physical exercise&#44; or other&#41;&#59; &#40;3&#41; if they were taking any statins &#40;regularly&#44; no&#44; irregularly&#41;&#59; and &#40;4&#41; if yes&#44; what statin preparation and what dose they were taking&#46; Compliance with statin therapy was assessed on the basis of the responses received and the regularity of statin intake&#46; A registration card was completed for each patient observed during this period&#46; The questionnaire and the registration card were developed by the researchers&#46; The questionnaire was filled in directly by the patient&#44; while the registration card &#40;including anthropometric&#44; clinical&#44; laboratory and test data&#44; and previous history&#41; was filled in by a physician&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Patients were divided into three age groups&#58; &#60;50 years old&#44; 50&#8211;70 years old&#44; and &#62;70 years old&#46; In addition&#44; the following factors were taken into account&#58; &#40;a&#41; alcohol consumption &#40;according to the questionnaire data&#41; &#8211; none&#44; occasional &#40;once or twice a week or less&#41;&#44; regularly &#40;three or more times a week&#41;&#59; &#40;b&#41; smoking status&#58; current smoker&#44; non-smoker&#44; former smoker&#59; &#40;c&#41; education&#58; higher education or not&#59; &#40;d&#41; statin dose&#58; low &#40;rosuvastatin &#60;10 mg&#44; atorvastatin &#60;20 mg&#44; simvastatin &#60;20 mg&#41;&#44; medium&#47;standard &#40;rosuvastatin 10&#8211;20 mg&#44; atorvastatin 20&#8211;40 mg&#44; simvastatin 20&#8211;40 mg&#41;&#44; high &#40;rosuvastatin &#62;20 mg&#59; atorvastatin &#62;40 mg&#59; simvastatin &#62;40 mg&#41;&#46; On the basis of these data patients&#8217; compliance with treatment and its effectiveness as shown by the results of further analysis were assessed&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">All patients gave their written informed consent for participation in the study and the questionnaire was approved by the Independent Ethics Committee of NRCPM&#46; Blood tests for cholesterol and its fractions were performed in the laboratory of NRCPM on the day of each patient&#39;s enrollment&#46;</p><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Statistical analysis</span><p id="par0035" class="elsevierStylePara elsevierViewall">The statistical data processing was performed using the Statistica 6&#46;0 software package &#40;StatSoft&#41;&#46; Data on the three groups are presented as median and interquartile range or as number and percentage of the total&#46; The chi-square test was used to compare groups for qualitative variables&#46; Rank analysis of variance using the Kruskal-Wallis test was used for multiple comparisons of quantitative variables between groups &#40;three or more&#41;&#46; Calculation of odds ratios &#40;OR&#41; and 95&#37; confidence intervals &#40;CI&#41; was carried out to determine the influence of various factors on regularity of statin intake in patients with cardiovascular disease&#46; OR were calculated on the basis of 2&#215;2 contingency tables&#44; in cells which accounted for the number of patients regularly and irregularly taking statins depending on the basic attributes analyzed&#46; Differences were considered statistically significant when p&#60;0&#46;05&#46;</p></span></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Results</span><p id="par0040" class="elsevierStylePara elsevierViewall">The present study included consecutive patients seen in the Preventive Pharmacotherapy Department between May 1 and December 31&#44; 2011&#46; During this period 274 patients were recorded in the registry&#46; Their main demographic and clinical characteristics are presented in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0050" class="elsevierStylePara elsevierViewall">Patients were divided into three groups according to how regularly they were taking statins&#58; regularly&#44; irregularly&#44; or none&#46; These groups were compared in terms of lipid profile &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">There were significant differences in total cholesterol and LDL cholesterol levels between patients regularly taking statins and patients not taking or irregularly taking statins &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figures 1 and 2</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">Odds ratios &#40;OR&#41; and their 95&#37; confidence intervals &#40;CI&#41; were calculated to determine the influence of various factors on regularity of statin intake &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Discussion and Conclusions</span><p id="par0065" class="elsevierStylePara elsevierViewall">The question of patients&#8217; compliance with prescribed therapy is extremely important&#44; especially concerning statins&#44; given their possible side effects that require dynamic control by biochemical blood tests&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">This study addresses these issues&#46; Certain limitations should be noted&#44; particularly the selectivity of the study population&#59; this was not an epidemiological study&#44; but an analysis of clinical practice that assessed ordinary patients&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">The criteria for statin use in this study were based on current guidelines&#58; patients with TC &#62;5 mmol&#47;l and LDL &#62;3 mmol&#47;l and high-risk patients with documented CHD&#44; previous MI or stroke or associated clinical conditions&#44; as well as with additional risk factors including TC &#62;4&#46;5 mmol&#47;l and LDL &#62;2&#46;5 mmol&#47;l&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">The study is relevant to the issue&#44; which has also been analyzed in other studies carried out in recent years&#46;<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">12&#8211;16</span></a> It is striking that our study&#44; which was small but governed strictly by guidelines for registries&#44; revealed such interesting data&#46; In our analysis of the factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry&#44; those that were most likely to increase the chances that the patient would take statins regularly were the presence of CHD and a history of MI and PCI &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>&#41;&#46; At the same time it should be noted that a history of stroke and the presence of diabetes did not motivate these patients to take statins on a regular basis&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">This can probably be explained by the fact that cardiologists are more likely to adhere to current international guidelines for the management of their patients and to prescribe statins&#44; in contrast to neurologists and endocrinologists&#44; who also often see patients with a history of stroke and diabetes&#44; respectively&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Ethical disclosures</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Protection of human and animal subjects</span><p id="par0090" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this study&#46;</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Confidentiality of data</span><p id="par0095" class="elsevierStylePara elsevierViewall">The authors declare that they have followed the protocols of their work center on the publication of patient data&#46;</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Right to privacy and informed consent</span><p id="par0100" class="elsevierStylePara elsevierViewall">The authors have obtained the written informed consent of the patients or subjects mentioned in the article&#46; The corresponding author is in possession of this document&#46;</p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Conflicts of interest</span><p id="par0105" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:12 [
        0 => array:3 [
          "identificador" => "xres439414"
          "titulo" => "Abstract"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Objective"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Methods"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Results"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec462603"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres439413"
          "titulo" => "Resumo"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Objetivo"
            ]
            1 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "M&#233;todos"
            ]
            2 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Resultados"
            ]
            3 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Conclus&#245;es"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec462602"
          "titulo" => "Palavras-chave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Objective"
        ]
        6 => array:3 [
          "identificador" => "sec0015"
          "titulo" => "Methods"
          "secciones" => array:1 [
            0 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Statistical analysis"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Results"
        ]
        8 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Discussion and Conclusions"
        ]
        9 => array:3 [
          "identificador" => "sec0035"
          "titulo" => "Ethical disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Protection of human and animal subjects"
            ]
            1 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Confidentiality of data"
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        10 => array:2 [
          "identificador" => "sec0055"
          "titulo" => "Conflicts of interest"
        ]
        11 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2014-06-05"
    "fechaAceptado" => "2014-08-16"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec462603"
          "palabras" => array:4 [
            0 => "Lipid-lowering therapy"
            1 => "Statins"
            2 => "Compliance"
            3 => "Registry"
          ]
        ]
      ]
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras-chave"
          "identificador" => "xpalclavsec462602"
          "palabras" => array:4 [
            0 => "Terap&#234;utica de redu&#231;&#227;o de l&#237;pidos"
            1 => "Estatinas"
            2 => "Ades&#227;o terap&#234;utica"
            3 => "Registo"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The aim of this study was to analyze the quality of lipid-lowering therapy in a cohort of patients with cardiovascular disease enrolled in a Moscow-based registry&#44; and to analyze the factors affecting the regularity of statin administration in this patient category&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The present study included all patients who successively sought medical advice in the Preventive Pharmacotherapy Department of the Ministry of Healthcare of the Russian Federation between May 1 and December 31&#44; 2011 &#40;n&#61;274&#41;&#46; Each patient was given a specially designed questionnaire in order to assess compliance with the prescribed treatment that included the following questions&#58; &#40;1&#41; if they knew&#44; according to the results of previous exams&#44; that they had elevated cholesterol levels &#40;yes&#44; no&#44; don&#8217;t know&#41;&#59; &#40;2&#41; what method of hypercholesterolemia correction they used &#40;diet&#44; medication&#44; physical exercise&#44; or other&#41;&#59; &#40;3&#41; if they were taking any statins &#40;regularly&#44; no&#44; irregularly&#41;&#59; and &#40;4&#41; if yes&#44; what statin preparation and what dose they were taking&#46; Patients&#8217; compliance with statin therapy was assessed on the basis of the responses received and the regularity of statin intake&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The influence of various factors on regularity of statin intake in patients with cardiovascular disease was assessed by calculating odds ratios &#40;OR&#41; and 95&#37; confidence intervals &#40;CI&#41; for advanced age &#40;&#62;70 years&#41; &#40;OR 0&#46;49&#41;&#59; higher statin dose than standard &#40;OR 0&#46;49&#41;&#59; hypertension &#40;OR 1&#46;659&#41;&#59; history of acute cerebrovascular event &#40;OR 2&#46;019&#41;&#59; diabetes &#40;OR 1&#46;023&#41;&#59; coronary heart disease &#40;CHD&#41; &#40;OR 4&#46;357&#41;&#59; history of myocardial infarction &#40;MI&#41; &#40;OR 4&#46;838&#41;&#59; history of coronary angiography&#47;percutaneous coronary intervention &#40;PCI&#41; &#40;OR 5&#46;167&#41;&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Analysis of factors with impact on regular compliance with statin therapy showed that the following were most significant&#58; CHD&#44; history of MI&#44; and history of PCI&#46; Previous cerebrovascular events and presence of diabetes did not motivate these patients to take statins on a regular basis&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Objective"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Methods"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "pt" => array:3 [
        "titulo" => "Resumo"
        "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">O objetivo deste estudo foi analisar a qualidade do tratamento hipolipemiante realizado numa coorte de pacientes portadores de doen&#231;as cardiovasculares&#44; obtido sob a forma de registo&#44; em Moscovo&#44; e analisar os fatores que afetam a regularidade da administra&#231;&#227;o de estatinas nesta categoria de pacientes&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">M&#233;todos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">O presente estudo incluiu todos os pacientes que consecutivamente procuraram aconselhamento m&#233;dico no Departamento de Farmacoterapia Preventiva durante o per&#237;odo de 1 de maio a 31 de dezembro 2011 &#40;n&#61;274&#41;&#46; Cada paciente recebeu um question&#225;rio especialmente concebido para avaliar a ades&#227;o dos pacientes ao tratamento realizado&#44; que incluiu as seguintes quest&#245;es&#58; 1&#41; se tem conhecimento de n&#237;veis elevados de colesterol&#44; de acordo com os exames realizados previamente &#40;sim&#44; n&#227;o&#44; desconhece&#41;&#59; 2&#41; que m&#233;todo utiliza para corre&#231;&#227;o da hipercolesterolemia &#40;dieta&#44; medica&#231;&#227;o&#44; exerc&#237;cio f&#237;sico&#44; outro&#41;&#59; 3&#41; se toma estatinas &#40;toma regularmente&#44; n&#227;o toma&#44; toma irregularmente&#41;&#59; 4&#41; se sim&#44; qual a estatina e a dose&#46; Com base nas resposta recebidas e regularidade da toma de estatinas&#44; foi efetuada a avalia&#231;&#227;o do conceito de ades&#227;o &#224; terap&#234;utica com estes f&#225;rmacos&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Para determinar o significado de uma s&#233;rie de fatores de acordo com a sua influ&#234;ncia sobre a regularidade da ingest&#227;o de estatinas em pacientes com doen&#231;as cardiovasculares&#44; foram calculados <span class="elsevierStyleItalic">odds ratio</span> &#40;OR&#41;&#58; idade avan&#231;ada &#40;&#62;70anos&#41; - OR de 0&#44;49&#59; aumento da dose de estatina &#8211; OR de 0&#44;49&#59; hipertens&#227;o arterial &#40;HA&#41; - OR de 1&#44;65&#59; hist&#243;ria pr&#233;via de doen&#231;a cerebrovascular aguda &#40;ACVD&#41;- OR de 2&#44;01&#59; diabetes <span class="elsevierStyleItalic">mellitus</span> &#40;DM&#41;- OR de 1&#44;02&#59; doen&#231;a arterial coron&#225;ria &#40;DAC&#41;- OR de 4&#44;35&#59; hist&#243;ria pr&#233;via de enfarte do mioc&#225;rdio &#40;IM&#41; &#8211; OR de 4&#44;83&#59; antecedenetes de angiografia coron&#225;ria &#40;CAG&#41;&#47;interven&#231;&#227;o coron&#225;ria percut&#226;nea &#40;ICP&#41; OR de 5&#44;16&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclus&#245;es</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">A an&#225;lise dos fatores com maior impacto sobre a ades&#227;o &#224; toma regular de estatinas mostrou serem mais significativos os seguintes&#58; CHD&#44; hist&#243;ria pr&#233;via de MI e de PCI&#46; Concomitantemente&#44; salienta-se que a hist&#243;ria pr&#233;via de ACVD e a presen&#231;a de DM n&#227;o motivaram estas classes de doentes a tomar estatinas de forma regular&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Objetivo"
          ]
          1 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "M&#233;todos"
          ]
          2 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Resultados"
          ]
          3 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Conclus&#245;es"
          ]
        ]
      ]
    ]
    "multimedia" => array:5 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1587
            "Ancho" => 1575
            "Tamanyo" => 150850
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Differences between groups by total cholesterol level&#46; 1&#58; taking statins regularly&#59; 2 not taking statins&#59; 3&#58; taking statins irregularly&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1593
            "Ancho" => 1578
            "Tamanyo" => 149939
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Differences between groups by LDL level&#46; 1&#58; taking statins regularly&#59; 2 not taking statins&#59; 3&#58; taking statins irregularly&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">BMI&#58; body mass index&#59; CABG&#58; coronary artery bypass grafting&#59; CAG&#58; coronary angiography&#59; CHD&#58; coronary heart disease&#59; HC&#58; hypercholesterolemia&#59; MI&#58; myocardial infarction&#59; PCI&#58; percutaneous coronary intervention&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Age&#44; years &#40;range&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">64&#46;0 &#40;57&#46;0&#8211;72&#46;0&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Male gender</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">135 &#40;49&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Higher education</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">231 &#40;84&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Currently employed</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">141 &#40;51&#46;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">BMI</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28&#46;7 &#40;25&#46;4&#8211;31&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Smoking</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">40 &#40;14&#46;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Baseline HC &#62;5&#46;0 mmol&#47;l</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">266 &#40;97&#46;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Current HC &#62;5&#46;0 mmol&#47;l</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">113 &#40;41&#46;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Current HC &#62;4&#46;5 mmol&#47;l</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">153 &#40;55&#46;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Diabetes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">43 &#40;15&#46;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Hypertension</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">230 &#40;83&#46;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">CHD</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">85 &#40;31&#46;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Angina CCS grade I-IV</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">66 &#40;24&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">History of MI</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">47 &#40;17&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Interventional procedures</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>CAG&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">50 &#40;18&#46;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>PCI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">22 &#40;8&#46;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>CABG&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9 &#40;3&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">History of stroke</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">19 &#40;6&#46;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Heart failure</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">50 &#40;18&#46;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab685927.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Main demographic and clinical characteristics of the study population&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">HDL&#58; high-density lipoprotein cholesterol&#59; LDL&#58; low-density lipoprotein cholesterol&#59; P25&#58; 25th percentile&#59; P75&#58; 75th percentile&#59; TC&#58; total cholesterol&#59; TG&#58; triglycerides&#59; VLDL&#58; very low density lipoprotein cholesterol&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " colspan="3" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Taking statins regularly</th><th class="td" title="table-head  " colspan="3" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Not taking statins</th><th class="td" title="table-head  " colspan="3" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Taking statins irregularly</th><th class="td" title="table-head  " align="left" valign="top" scope="col">p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Median&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P75&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Median&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P75&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Median&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P75&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">TC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;80&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;08&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;88&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;20&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">7&#46;10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;20&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&#46;50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;0001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">LDL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;57&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;00&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;06&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;89&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;21&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;54&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;43&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;38&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;48&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;0001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">VLDL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;62&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;53&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;76&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;62&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;53&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;76&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;55&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;44&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;79&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;6456&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">HDL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;17&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;95&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;43&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;19&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;95&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;43&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;22&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;08&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;41&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;8905&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">TG&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;28&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;08&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;33&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;08&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;20&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;97&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;58&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;5421&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab685928.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Comparisons between groups according to lipid profile&#46;</p>"
        ]
      ]
      4 => array:7 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">CAG&#58; coronary angiography&#59; CHD&#58; coronary heart disease&#59; CI&#58; confidence interval&#59; PCI&#58; percutaneous coronary intervention&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">OR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">95&#37; CI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " colspan="4" align="left" valign="top"><span class="elsevierStyleItalic">Sociodemographic variables</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Elderly age &#40;&#62;70 years&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;429&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;224&#8211;0&#46;822&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;015&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Higher statin dose than standard&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;49&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;169&#8211;1&#46;423&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;306&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Smoking&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;607&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;812&#8211;1&#46;404&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;342&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Education&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;855&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;384&#8211;1&#46;906&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;86&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Avoidance of alcohol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;145&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;640&#8211;2&#46;049&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;757&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Male gender&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;775&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;993&#8211;3&#46;173&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;072&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Currently employed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;966&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;694&#8211;4&#46;322&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;129&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="4" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="4" align="left" valign="top"><span class="elsevierStyleItalic">Clinical variables</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Diabetes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;023&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;489&#8211;2&#46;138&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;898&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Hypertension&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;659&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;692&#8211;3&#46;979&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;365&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>History of stroke&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;019&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;631&#8211;6&#46;463&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;347&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>CHD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;357&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;188&#8211;8&#46;677&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;0001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>History of MI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;838&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;765&#8211;13&#46;259&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;002&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>History of CAG&#47;PCI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;167&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;055&#8211;12&#46;99&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;0001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab685926.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Influence of major factors on regularity of statin intake&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:16 [
            0 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Task Force for the management of dyslipidaemias of the European Society of Cardiology &#40;ESC&#41; and the European Atherosclerosis Society &#40;EAS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "ESC&#47;EAS Guidelines for the management of dyslipidaemias"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehr158"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Heart J"
                        "fecha" => "2011"
                        "volumen" => "32"
                        "paginaInicial" => "1769"
                        "paginaFinal" => "1818"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21712404"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "LongTerm Intervention with Pravastatin in Ischaemic Disease &#40;LIPID&#41; Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Eng J Med"
                        "fecha" => "1998"
                        "volumen" => "339"
                        "paginaInicial" => "1349"
                        "paginaFinal" => "1357"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Reduction of stroke incidence after myocardial infarction with pravastatin&#58; the Cholesterol and Recurrent Events &#40;CARE&#41; study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;F&#46; Plehn"
                            1 => "B&#46;R&#46; Davis"
                            2 => "F&#46;M&#46; Sacks"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "1999"
                        "volumen" => "99"
                        "paginaInicial" => "216"
                        "paginaFinal" => "223"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9892586"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "MRC&#47;BHF Heart Protection Study of cholesterol lowering with simvastatin in 20&#44;536 high-risk individuals&#58; a randomised placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "Heart Protection Study Collaborative Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(02)09327-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2002"
                        "volumen" => "360"
                        "paginaInicial" => "7"
                        "paginaFinal" => "22"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12114036"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "West of Scotland Coronary Prevention Study&#58; identification of high-risk groups and comparison with other cardiovascular intervention trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "West of Scotland Coronary Prevention Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "1996"
                        "volumen" => "348"
                        "paginaInicial" => "1339"
                        "paginaFinal" => "1342"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8918276"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "for the AFCAPS&#47;TexCAPS Research Group"
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;R&#46; Downs"
                            1 => "M&#46; Clearfield"
                            2 => "S&#46; Weis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA"
                        "fecha" => "1998"
                        "volumen" => "279"
                        "paginaInicial" => "1615"
                        "paginaFinal" => "1622"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9613910"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations&#44; in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm &#40;ASCOT-LLA&#41;&#58; a multicentre randomised controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "P&#46;S&#46; Sever"
                            1 => "B&#46; Dahlof"
                            2 => "N&#46;R&#46; Poulter"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(03)12948-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2003"
                        "volumen" => "361"
                        "paginaInicial" => "1149"
                        "paginaFinal" => "1158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12686036"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Use of secondary prevention drugs for cardiovascular disease in the community in high-income&#44; middle-income&#44; and low-income countries &#40;the PURE Study&#41;&#58; a prospective epidemiological survey"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "S&#46; Yusuf"
                            1 => "S&#46; Islam"
                            2 => "C&#46;K&#46; Chow"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(11)61215-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2011"
                        "volumen" => "378"
                        "paginaInicial" => "1231"
                        "paginaFinal" => "1243"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21872920"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Main results of the Moscow Research on Statines &#40;to Moscow Statin Survey&#44; MSS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46;V&#46; Susekov"
                            1 => "M&#46;Yu&#46; Zubareva"
                            2 => "A&#46;D&#46; Deev"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Serdce"
                        "fecha" => "2006"
                        "paginaInicial" => "324"
                        "paginaFinal" => "328"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Using registers to study effectiveness and safety of drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "S&#46;Yu&#46; Martsevich"
                            1 => "L&#46;Yu&#46; Drozdova"
                            2 => "N&#46;P&#46; Kutishenko"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Clinician"
                        "fecha" => "2012"
                        "volumen" => "3&#8211;4"
                        "paginaInicial" => "4"
                        "paginaFinal" => "9"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The LIS study &#40;Lubertsy study of mortality in patients with acute myocardial infarction&#41;&#46; Evaluation of pharmacotherapy&#46; Part 1&#46; Treatment of patients before myocardial infarction and its influence on hospital mortality"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "S&#46;Yu&#46; Martsevich"
                            1 => "M&#46;L&#46; Ginzburg"
                            2 => "N&#46;P&#46; Kutishenko"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rational Pharmacother Card"
                        "fecha" => "2012"
                        "volumen" => "8"
                        "paginaInicial" => "681"
                        "paginaFinal" => "684"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease&#58; a population-level study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "N&#46;M&#46; Ivers"
                            1 => "J&#46;D&#46; Schwalm"
                            2 => "C&#46;A&#46; Jackevicius"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.cjca.2013.04.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Can J Cardiol"
                        "fecha" => "2013"
                        "volumen" => "29"
                        "paginaInicial" => "1408"
                        "paginaFinal" => "1414"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23816280"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "V&#46;G&#46; Vimalananda"
                            1 => "D&#46;R&#46; Miller"
                            2 => "T&#46;P&#46; Hofer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s11606-013-2340-5"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Gen Intern Med"
                        "fecha" => "2013"
                        "volumen" => "28"
                        "numero" => "Suppl 2"
                        "paginaInicial" => "S529"
                        "paginaFinal" => "S535"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23807061"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis&#59; REduction of Atherothrombosis for Continued Health Registry Investigators"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "D&#46;J&#46; Kumbhani"
                            1 => "P&#46;G&#46; Steg"
                            2 => "C&#46;P&#46; Cannon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjmed.2013.01.033"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "2013"
                        "volumen" => "126"
                        "paginaInicial" => "693"
                        "paginaFinal" => "700"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23800583"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Factors influencing adherence in long-term use of statins"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;R&#46; Warren"
                            1 => "M&#46;O&#46; Falster"
                            2 => "D&#46; Fox"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/pds.3526"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pharmacoepidemiol Drug Saf"
                        "fecha" => "2013"
                        "volumen" => "22"
                        "paginaInicial" => "1298"
                        "paginaFinal" => "1307"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24105731"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Use of health information technology &#40;HIT&#41; to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients&#58; proceedings from a workshop"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;D&#46; Cohen"
                            1 => "K&#46;E&#46; Aspry"
                            2 => "A&#46;S&#46; Brown"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jacl.2013.10.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Lipidol"
                        "fecha" => "2013"
                        "volumen" => "7"
                        "paginaInicial" => "573"
                        "paginaFinal" => "609"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24314357"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21742049/0000003400000002/v2_201502270337/S217420491500032X/v2_201502270337/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9912"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21742049/0000003400000002/v2_201502270337/S217420491500032X/v2_201502270337/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217420491500032X?idApp=UINPBA00004E"
]
Share
Journal Information
Vol. 34. Issue 2.
Pages 111-116 (February 2015)
Share
Share
Download PDF
More article options
Visits
6394
Vol. 34. Issue 2.
Pages 111-116 (February 2015)
Original Article
Open Access
Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry
Análise da terapêutica de redução lipídica e dos fatores que afetam a regularidade da toma de estatinas em doentes com doenças cardiovasculares inseridos no Registo Profile
Visits
6394
Oleg Gaisenoka,b,
Corresponding author
ogaisenok@gnicpm.ru

Corresponding author.
, Sergey Martsevicha,c, Svetlana Tripkosha, Yulia Lukinaa,c
a FGBI “National Research Centre of Preventive Medicine” of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
b FGBI “Joint Hospital and Polyclinic” Department of Presidential Affairs of the Russian Federation, Moscow, Russia
c IM. Sechenov First Moscow State Medical University, Moscow, Russia
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (3)
Table 1. Main demographic and clinical characteristics of the study population.
Table 2. Comparisons between groups according to lipid profile.
Table 3. Influence of major factors on regularity of statin intake.
Show moreShow less
Abstract
Objective

The aim of this study was to analyze the quality of lipid-lowering therapy in a cohort of patients with cardiovascular disease enrolled in a Moscow-based registry, and to analyze the factors affecting the regularity of statin administration in this patient category.

Methods

The present study included all patients who successively sought medical advice in the Preventive Pharmacotherapy Department of the Ministry of Healthcare of the Russian Federation between May 1 and December 31, 2011 (n=274). Each patient was given a specially designed questionnaire in order to assess compliance with the prescribed treatment that included the following questions: (1) if they knew, according to the results of previous exams, that they had elevated cholesterol levels (yes, no, don’t know); (2) what method of hypercholesterolemia correction they used (diet, medication, physical exercise, or other); (3) if they were taking any statins (regularly, no, irregularly); and (4) if yes, what statin preparation and what dose they were taking. Patients’ compliance with statin therapy was assessed on the basis of the responses received and the regularity of statin intake.

Results

The influence of various factors on regularity of statin intake in patients with cardiovascular disease was assessed by calculating odds ratios (OR) and 95% confidence intervals (CI) for advanced age (>70 years) (OR 0.49); higher statin dose than standard (OR 0.49); hypertension (OR 1.659); history of acute cerebrovascular event (OR 2.019); diabetes (OR 1.023); coronary heart disease (CHD) (OR 4.357); history of myocardial infarction (MI) (OR 4.838); history of coronary angiography/percutaneous coronary intervention (PCI) (OR 5.167).

Conclusions

Analysis of factors with impact on regular compliance with statin therapy showed that the following were most significant: CHD, history of MI, and history of PCI. Previous cerebrovascular events and presence of diabetes did not motivate these patients to take statins on a regular basis.

Keywords:
Lipid-lowering therapy
Statins
Compliance
Registry
Resumo
Objetivo

O objetivo deste estudo foi analisar a qualidade do tratamento hipolipemiante realizado numa coorte de pacientes portadores de doenças cardiovasculares, obtido sob a forma de registo, em Moscovo, e analisar os fatores que afetam a regularidade da administração de estatinas nesta categoria de pacientes.

Métodos

O presente estudo incluiu todos os pacientes que consecutivamente procuraram aconselhamento médico no Departamento de Farmacoterapia Preventiva durante o período de 1 de maio a 31 de dezembro 2011 (n=274). Cada paciente recebeu um questionário especialmente concebido para avaliar a adesão dos pacientes ao tratamento realizado, que incluiu as seguintes questões: 1) se tem conhecimento de níveis elevados de colesterol, de acordo com os exames realizados previamente (sim, não, desconhece); 2) que método utiliza para correção da hipercolesterolemia (dieta, medicação, exercício físico, outro); 3) se toma estatinas (toma regularmente, não toma, toma irregularmente); 4) se sim, qual a estatina e a dose. Com base nas resposta recebidas e regularidade da toma de estatinas, foi efetuada a avaliação do conceito de adesão à terapêutica com estes fármacos.

Resultados

Para determinar o significado de uma série de fatores de acordo com a sua influência sobre a regularidade da ingestão de estatinas em pacientes com doenças cardiovasculares, foram calculados odds ratio (OR): idade avançada (>70anos) - OR de 0,49; aumento da dose de estatina – OR de 0,49; hipertensão arterial (HA) - OR de 1,65; história prévia de doença cerebrovascular aguda (ACVD)- OR de 2,01; diabetes mellitus (DM)- OR de 1,02; doença arterial coronária (DAC)- OR de 4,35; história prévia de enfarte do miocárdio (IM) – OR de 4,83; antecedenetes de angiografia coronária (CAG)/intervenção coronária percutânea (ICP) OR de 5,16.

Conclusões

A análise dos fatores com maior impacto sobre a adesão à toma regular de estatinas mostrou serem mais significativos os seguintes: CHD, história prévia de MI e de PCI. Concomitantemente, salienta-se que a história prévia de ACVD e a presença de DM não motivaram estas classes de doentes a tomar estatinas de forma regular.

Palavras-chave:
Terapêutica de redução de lípidos
Estatinas
Adesão terapêutica
Registo
Full Text
Introduction

The value of statins to achieve target levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides is emphasized in current international guidelines.1 The relationship between LDL level and frequency of cardiovascular events has been confirmed in large studies.2–7 However, clinicians do not always follow the recommendations.8 The situation with regard to the use of lipid-lowering drugs in Russia is particularly difficult. A study of statin use in Moscow obtained the following results: only 30% of patients with coronary heart disease (CHD) took statins; 80% of prescriptions were for simvastatin or lovastatin at initial doses; and mean duration of treatment was five months.9 However, this study investigated selective samples of patients. Data that are more relevant to clinical practice are obtained from studies conducted using the principles of consistent inclusion of patients, i.e. under registry rules.10 Analysis of the drugs taken as outpatients by high-risk patients before a reference myocardial infarction in the LIS study enrolled in the hospital's registry showed that the frequency of statin use was only 2%.11 With modern cardiovascular disease registries it is possible not only to determine the frequency of drug prescriptions but also to assess the factors that influence compliance with medication.

Objective

The aim of this study was to analyze the quality of lipid-lowering therapy in a cohort of patients with cardiovascular disease enrolled in a Moscow-based registry, and to analyze the factors affecting the regularity of statin administration in this patient category.

Methods

The PROFILE registry is a outpatient registry compiled by the Preventive Pharmacotherapy Department of the National Research Center for Preventive Medicine (NRCPM) of the Ministry of Healthcare of the Russian Federation. NRCPM is a federal medical center to which patients from other medical institutions (including municipal) are referred to seek medical advice. The PROFILE registry includes all patients presenting to the department for consultations on cardiovascular disease.

This study included all patients who sought medical advice in the Preventive Pharmacotherapy Department between May 1 and December 31, 2011. Each patient was given a specially designed questionnaire in order to assess compliance with the prescribed treatment. Patients were required to answer the following questions: (1) if they knew, according to the results of previous exams, that they had elevated cholesterol levels (yes, no, don’t know); (2) what method of hypercholesterolemia correction they used (diet, medication, physical exercise, or other); (3) if they were taking any statins (regularly, no, irregularly); and (4) if yes, what statin preparation and what dose they were taking. Compliance with statin therapy was assessed on the basis of the responses received and the regularity of statin intake. A registration card was completed for each patient observed during this period. The questionnaire and the registration card were developed by the researchers. The questionnaire was filled in directly by the patient, while the registration card (including anthropometric, clinical, laboratory and test data, and previous history) was filled in by a physician.

Patients were divided into three age groups: <50 years old, 50–70 years old, and >70 years old. In addition, the following factors were taken into account: (a) alcohol consumption (according to the questionnaire data) – none, occasional (once or twice a week or less), regularly (three or more times a week); (b) smoking status: current smoker, non-smoker, former smoker; (c) education: higher education or not; (d) statin dose: low (rosuvastatin <10 mg, atorvastatin <20 mg, simvastatin <20 mg), medium/standard (rosuvastatin 10–20 mg, atorvastatin 20–40 mg, simvastatin 20–40 mg), high (rosuvastatin >20 mg; atorvastatin >40 mg; simvastatin >40 mg). On the basis of these data patients’ compliance with treatment and its effectiveness as shown by the results of further analysis were assessed.

All patients gave their written informed consent for participation in the study and the questionnaire was approved by the Independent Ethics Committee of NRCPM. Blood tests for cholesterol and its fractions were performed in the laboratory of NRCPM on the day of each patient's enrollment.

Statistical analysis

The statistical data processing was performed using the Statistica 6.0 software package (StatSoft). Data on the three groups are presented as median and interquartile range or as number and percentage of the total. The chi-square test was used to compare groups for qualitative variables. Rank analysis of variance using the Kruskal-Wallis test was used for multiple comparisons of quantitative variables between groups (three or more). Calculation of odds ratios (OR) and 95% confidence intervals (CI) was carried out to determine the influence of various factors on regularity of statin intake in patients with cardiovascular disease. OR were calculated on the basis of 2×2 contingency tables, in cells which accounted for the number of patients regularly and irregularly taking statins depending on the basic attributes analyzed. Differences were considered statistically significant when p<0.05.

Results

The present study included consecutive patients seen in the Preventive Pharmacotherapy Department between May 1 and December 31, 2011. During this period 274 patients were recorded in the registry. Their main demographic and clinical characteristics are presented in Table 1.

Table 1.

Main demographic and clinical characteristics of the study population.

Age, years (range)  64.0 (57.0–72.0) 
Male gender  135 (49.3%) 
Higher education  231 (84.3%) 
Currently employed  141 (51.4%) 
BMI  28.7 (25.4–31.3) 
Smoking  40 (14.6%) 
Baseline HC >5.0 mmol/l  266 (97.0%) 
Current HC >5.0 mmol/l  113 (41.2%) 
Current HC >4.5 mmol/l  153 (55.8%) 
Diabetes  43 (15.7%) 
Hypertension  230 (83.9%) 
CHD  85 (31.0%) 
Angina CCS grade I-IV  66 (24.1%) 
History of MI  47 (17.1%) 
Interventional procedures
CAG  50 (18.2%) 
PCI  22 (8.0%) 
CABG  9 (3.3%) 
History of stroke  19 (6.9%) 
Heart failure  50 (18.2%) 

BMI: body mass index; CABG: coronary artery bypass grafting; CAG: coronary angiography; CHD: coronary heart disease; HC: hypercholesterolemia; MI: myocardial infarction; PCI: percutaneous coronary intervention.

Patients were divided into three groups according to how regularly they were taking statins: regularly, irregularly, or none. These groups were compared in terms of lipid profile (Table 2).

Table 2.

Comparisons between groups according to lipid profile.

  Taking statins regularlyNot taking statinsTaking statins irregularly
  Median  P25  P75  Median  P25  P75  Median  P25  P75   
TC  4.50  3.80  5.08  5.88  5.20  7.10  5.10  4.20  6.50  0.0001 
LDL  2.57  2.00  3.06  3.89  3.21  4.54  3.43  2.38  4.48  0.0001 
VLDL  0.62  0.53  0.76  0.62  0.53  0.76  0.55  0.44  0.79  0.6456 
HDL  1.17  0.95  1.43  1.19  0.95  1.43  1.22  1.08  1.41  0.8905 
TG  1.28  1.08  1.65  1.33  1.08  1.65  1.20  0.97  2.58  0.5421 

HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; P25: 25th percentile; P75: 75th percentile; TC: total cholesterol; TG: triglycerides; VLDL: very low density lipoprotein cholesterol.

There were significant differences in total cholesterol and LDL cholesterol levels between patients regularly taking statins and patients not taking or irregularly taking statins (Figures 1 and 2).

Figure 1.

Differences between groups by total cholesterol level. 1: taking statins regularly; 2 not taking statins; 3: taking statins irregularly.

(0.14MB).
Figure 2.

Differences between groups by LDL level. 1: taking statins regularly; 2 not taking statins; 3: taking statins irregularly.

(0.14MB).

Odds ratios (OR) and their 95% confidence intervals (CI) were calculated to determine the influence of various factors on regularity of statin intake (Table 3).

Table 3.

Influence of major factors on regularity of statin intake.

  OR  95% CI 
Sociodemographic variables
Elderly age (>70 years)  0.429  0.224–0.822  0.015 
Higher statin dose than standard  0.49  0.169–1.423  0.306 
Smoking  0.607  0.812–1.404  0.342 
Education  0.855  0.384–1.906  0.86 
Avoidance of alcohol  1.145  0.640–2.049  0.757 
Male gender  1.775  0.993–3.173  0.072 
Currently employed  1.966  0.694–4.322  0.129 
Clinical variables
Diabetes  1.023  0.489–2.138  0.898 
Hypertension  1.659  0.692–3.979  0.365 
History of stroke  2.019  0.631–6.463  0.347 
CHD  4.357  2.188–8.677  0.0001 
History of MI  4.838  1.765–13.259  0.002 
History of CAG/PCI  5.167  2.055–12.99  0.0001 

CAG: coronary angiography; CHD: coronary heart disease; CI: confidence interval; PCI: percutaneous coronary intervention.

Discussion and Conclusions

The question of patients’ compliance with prescribed therapy is extremely important, especially concerning statins, given their possible side effects that require dynamic control by biochemical blood tests.

This study addresses these issues. Certain limitations should be noted, particularly the selectivity of the study population; this was not an epidemiological study, but an analysis of clinical practice that assessed ordinary patients.

The criteria for statin use in this study were based on current guidelines: patients with TC >5 mmol/l and LDL >3 mmol/l and high-risk patients with documented CHD, previous MI or stroke or associated clinical conditions, as well as with additional risk factors including TC >4.5 mmol/l and LDL >2.5 mmol/l.

The study is relevant to the issue, which has also been analyzed in other studies carried out in recent years.12–16 It is striking that our study, which was small but governed strictly by guidelines for registries, revealed such interesting data. In our analysis of the factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry, those that were most likely to increase the chances that the patient would take statins regularly were the presence of CHD and a history of MI and PCI (Table 3). At the same time it should be noted that a history of stroke and the presence of diabetes did not motivate these patients to take statins on a regular basis.

This can probably be explained by the fact that cardiologists are more likely to adhere to current international guidelines for the management of their patients and to prescribe statins, in contrast to neurologists and endocrinologists, who also often see patients with a history of stroke and diabetes, respectively.

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent

The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Conflicts of interest

The authors have no conflicts of interest to declare.

References
[1]
ESC/EAS Guidelines for the management of dyslipidaemias.
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Eur Heart J, 32 (2011), pp. 1769-1818
[2]
LongTerm Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
N Eng J Med, 339 (1998), pp. 1349-1357
[3]
J.F. Plehn, B.R. Davis, F.M. Sacks, et al.
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study.
Circulation, 99 (1999), pp. 216-223
[4]
Heart Protection Study Collaborative Group.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
[5]
West of Scotland Coronary Prevention Group.
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.
Lancet, 348 (1996), pp. 1339-1342
[6]
J.R. Downs, M. Clearfield, S. Weis, for the AFCAPS/TexCAPS Research Group, et al.
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels.
JAMA, 279 (1998), pp. 1615-1622
[7]
P.S. Sever, B. Dahlof, N.R. Poulter, et al.
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Lancet, 361 (2003), pp. 1149-1158
[8]
S. Yusuf, S. Islam, C.K. Chow, et al.
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
Lancet, 378 (2011), pp. 1231-1243
[9]
A.V. Susekov, M.Yu. Zubareva, A.D. Deev, et al.
Main results of the Moscow Research on Statines (to Moscow Statin Survey, MSS).
Serdce, (2006), pp. 324-328
[10]
S.Yu. Martsevich, L.Yu. Drozdova, N.P. Kutishenko, et al.
Using registers to study effectiveness and safety of drugs.
Clinician, 3–4 (2012), pp. 4-9
[11]
S.Yu. Martsevich, M.L. Ginzburg, N.P. Kutishenko, et al.
The LIS study (Lubertsy study of mortality in patients with acute myocardial infarction). Evaluation of pharmacotherapy. Part 1. Treatment of patients before myocardial infarction and its influence on hospital mortality.
Rational Pharmacother Card, 8 (2012), pp. 681-684
[12]
N.M. Ivers, J.D. Schwalm, C.A. Jackevicius, et al.
Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
Can J Cardiol, 29 (2013), pp. 1408-1414
[13]
V.G. Vimalananda, D.R. Miller, T.P. Hofer, et al.
Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans.
J Gen Intern Med, 28 (2013), pp. S529-S535
[14]
D.J. Kumbhani, P.G. Steg, C.P. Cannon, et al.
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis; REduction of Atherothrombosis for Continued Health Registry Investigators.
Am J Med, 126 (2013), pp. 693-700
[15]
J.R. Warren, M.O. Falster, D. Fox, et al.
Factors influencing adherence in long-term use of statins.
Pharmacoepidemiol Drug Saf, 22 (2013), pp. 1298-1307
[16]
J.D. Cohen, K.E. Aspry, A.S. Brown, et al.
Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: proceedings from a workshop.
J Clin Lipidol, 7 (2013), pp. 573-609
Copyright © 2014. Sociedade Portuguesa de Cardiologia
Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.